The Discounted Cash Flow (DCF) valuation of 4D Molecular Therapeutics Inc (FDMT) is (93.55) USD. With the latest stock price at 4.22 USD, the upside of 4D Molecular Therapeutics Inc based on DCF is -2316.7%.
Based on the latest price of 4.22 USD and our DCF valuation, 4D Molecular Therapeutics Inc (FDMT) is a sell. selling FDMT stocks now will result in a potential gain of 2316.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.3% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (702.39) - (50.32) | (93.55) |
| Upside | -16744.4% - -1292.5% | -2316.7% |